#PersonalisedMedicine
#SYNTHIA Insight 1 explores how AI-generated multimodal #syntheticdata can advance #bloodcancer research, supporting better disease classification, biomarker discovery and personalised treatments.

Learn more: www.ihi-synthia.eu/news/synthia...
#PersonalisedMedicine #IHITransformingHealth #HorizonEU
October 27, 2026 at 10:04 AM
Most people choose vitamin D based on shelf options—but the dose that works depends entirely on your baseline blood level. A 5,000 IU supplement raise…

#Clinicalnutrition #Doseresponse #Personalisedmedicine #Supplementation #VitaminD

#Clinicalnutrition #Doseresponse #Personalisedmedicine #Suppl…
Why Your Vitamin D Dose Matters More Than the Bottle
Most people choose vitamin D based on shelf options—but the dose that works depends entirely on your baseline blood level. A 5,000 IU supplement raise… #Clinicalnutrition #Doseresponse #Personalisedmedicine #Supplementation #VitaminD
news.gmj.ge
October 22, 2026 at 5:27 AM
🌍 Meet #SYNTHIA at #ESMO2026 in Madrid!

🎤 On 23 October, our Partner Adrián Galiana Bordera (IISLaFe) will join the IAPM Policy Meeting.

🔗 www.ihi-synthia.eu/meet-us/synt...

#SyntheticData #PersonalisedMedicine #IHITransformingHealth #HorizonEU
October 22, 2026 at 11:03 AM
vimeo.com/1140761225/a...
🎥 This week we're looking back at #BSGM2025. Thank you Demetra Georgiou, Vice Chair of the British Society of Genomic Medicine, for sharing at the conference.
Join us at the BSGM Annual Conference 2026! #genetics #genomics #genomicmedicine #personalisedmedicine #biology
Demetra Georgiou - subtitled
This is "Demetra Georgiou - subtitled" by Cerebrus Digital on Vimeo, the home for high quality videos and the people who love them.
vimeo.com
October 7, 2026 at 9:00 AM
Prof. Luis Martí-Bonmatí will present #SYNTHIA’s work on #syntheticdata, cancer research, medical imaging & AI at #EUCancerMission: Stronger Through Connection.
📅 29 Sep–1 Oct

#PersonalisedMedicine #AIinHealthcare #EUResearch #DataInnovation #IHITransformingHealth #HorizonEU
September 25, 2026 at 2:57 PM
🧬#SYNTHIA is heading to Paris!

On 5 Oct, Ahmed Youssef Ali will represent #SYNTHIA at the #SHAIPED Stakeholder Forum, joining discussions on whether health data is truly AI-ready.

#SyntheticData #PersonalisedMedicine #AIinHealthcare #EUResearch #DataInnovation #IHITransformingHealth #HorizonEU
September 25, 2026 at 2:58 PM
That is a wrap on #SYNTHIA GA2026! 🇩🇪
Two days of valuable discussions, new insights & collaboration as we shape the next phase of SYNTHIA.
Thank you to all our partners & speakers, and to our hosts Fraunhofer & Gates Ventures! 🤝
#SyntheticData #PersonalisedMedicine #IHITransformingHealth #HorizonEU
September 23, 2026 at 1:33 PM
🔬 The PICKED network met in Tallinn to share research progress and explore biomarkers, computational modelling, treatment response, entrepreneurship and patenting.

📖 Read more: lnkd.in/ec4-6iCv

#PICKEDProject #KidneyResearch #PersonalisedMedicine #MSCA
September 22, 2026 at 9:39 AM
We are heading to Tallinn on 16–17 September 2026

The meeting will bring together Doctoral Candidates, supervisors and invited experts.

Read more:
🔗 www.projectpicked.eu/news-and-eve...

#MSCA #KidneyResearch #PersonalisedMedicine #HorizonEurope
News and Events
Stay updated with the latest news, events, and milestones from the PICKED Project as we advance personalized kidney care through research.
www.projectpicked.eu
September 10, 2026 at 9:43 AM
Critical care specialists Jan Rossaint and Alexander Zarbock are seeing some initial successes with #PersonalisedMedicine to fight life-threatening #SystemicInflammations. To mark World #Sepsis Day on 13 September, they give insights into the latest research. #WorldSepsisDay
Initial successes with personalised medicine to fight severe systemic inflammation
To mark World Sepsis Day on 13 September, critical care specialists Professor Jan Rossaint and Professor Alexander Zarbock from the University of Münster give insights into the latest research on seps...
www.uni-muenster.de
September 9, 2026 at 11:38 AM
The microbiome may be tiny, but the data challenge isn’t!

#MicrobAIome combines microbiome research, clinical knowledge and AI to better understand the complex links between our microbiome and health.

#Microbiome #AI #PersonalisedMedicine #HorizonEurope
August 28, 2026 at 9:09 PM
Can personalised medicine be truly personalised if access is unequal?

Advanced diagnostics, biomarkers and digital tools may not be equally available to every patient.

#PersonalisedMedicine #HealthEquity #KidneyResearch #PICKEDproject
August 25, 2026 at 8:32 AM
🔬 Difficult-to-treat
When options run out, what works?

🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w

#RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine
Flash Science in Rheumatology, Episode 6: Therapeutic approaches for difficult-to-treat RA
YouTube video by Division of Rheumatology - MUW Vienna
youtu.be
August 24, 2026 at 7:57 PM
US Scientists have obtained the most complete and accurate sequence of a human diploid reference genome to date, paving the way for personalised medicine.
Grace Woolston explains in BioNews: www.progress.org.uk/human-genome...

#Genome #PersonalisedMedicine #HumanGenome #Sequencing #DNA
August 24, 2026 at 7:45 PM
📍 Meet SYNTHIA at #ECCB2026!

SYNTHIA partner Stella Fragkouli from CERTH will present research on evaluation metrics for synthetic data in life sciences.

#SYNTHIA #SyntheticData #PersonalisedMedicine #HealthInnovation #AIinHealthcare #EUResearch #DataInnovation #IHITransformingHealth #HorizonEU
August 24, 2026 at 9:21 AM
August 18, 2026 at 9:09 AM
Where you live affects your exposure to cancer-causing substances - and scientists can read these exposures in your DNA.

Geographic variation of mutagenic exposures in kidney cancer genomes.

www.nature.com/articles/s41...

#mutations #genomics #cancer #oncology #personalisedmedicine
Geographic variation of mutagenic exposures in kidney cancer genomes - Nature
Whole-genome sequencing of 962 clear cell renal cell carcinomas from 11 countries shows geographic variations in somatic mutation profiles, including a mutational signature of unknown cause in 70% of ...
www.nature.com
August 16, 2026 at 11:56 AM
Newly discovered link between Traumatic Brain Injury in children and epigenetic changes could help personalize treatment for recovering kids

#BrainInjury #TBI #Epigenetics #PersonalisedMedicine

theconversation.com/newly-discov...
Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
Some children recover better after traumatic brain injury than others, despite appearing similarly to doctors. Looking at the genetic and cellular level, however, reveal key differences.
theconversation.com
December 10, 2025 at 1:08 AM
When we can spare patients ineffective treatment and focus on what is more likely to help, that is not just smarter medicine, it is kinder medicine too. #CancerResearch #PersonalisedMedicine #TCSC
April 15, 2026 at 9:31 AM
What if one test could match you with the right cancer treatment from the start? Dana-Farber researchers may have just brought us closer to that reality. Precision over guesswork; finally. #CancerResearch #TCSC #PersonalisedMedicine

oncodaily.com/insight/test...
What If One Test Could Find Your Best Cancer Treatment? - Dana-Farber Cancer Institute - OncoDaily
What If One Test Could Find Your Best Cancer Treatment? - Dana-Farber Cancer Institute / cancer, Dana-Farber Cancer Institute, Keith Ligon, Kin-Hoe Chow,
oncodaily.com
July 21, 2025 at 9:28 AM
Chemo gets clever: A molecular test helps pinpoint which early-stage NSCLC patients will benefit most from chemo; boosting survival & precision. #TCSC #LungCancer #NSCLC #PersonalisedMedicine #OncologyBreakthrough #CancerTreatment #AdjuvantChemo #MolecularAssay

www.targetedonc.com/view/molecul...
Molecularly Guided Chemotherapy Boosts Survival in Early NSCLC
A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy, improving survival without disease progression.
www.targetedonc.com
June 6, 2025 at 7:28 AM